Pfizer (NY:PFE)

As of December 22, 2025, the global equity markets are witnessing a historic recalibration of the healthcare sector. For decades, the "Trillion Dollar Club" was an exclusive enclave for Silicon...

The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond

December 22, 2025

As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare...

Topics Economy Intellectual Property

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...

Topics Economy Intellectual Property

Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive

December 22, 2025

Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? ↗

Topics Earnings Initial Public Offering Intellectual Property

December 22, 2025

Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.

This year has been one to forget for these pharmaceutical giants.

MarketBeat Week in Review – 12/15 - 12/19 ↗

December 20, 2025

Via MarketBeat

Better Buy in 2026: Pfizer or Merck? ↗

December 19, 2025

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

Topics Intellectual Property

December 19, 2025

The deals expand the pricing program to most targeted drugmakers in exchange for temporary tariff relief.

Via Stocktwits

Topics Government World Trade

Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗

December 19, 2025

Dow Jones stock Merck forged a Most Favored Nation agreement with the Trump administration on Friday.

Via Investor's Business Daily

Topics Government Stocks

Friday's session: most active stock in the S&P500 index ↗

December 19, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Friday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Down 80%, Should You Buy the Dip on Moderna? ↗

December 19, 2025

Your decision on whether to invest now depends to some extent on your investment strategy.

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm

December 18, 2025

Via StockStory

Topics Stocks

3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗

December 18, 2025

The stocks listed here trade at forward earnings multiples of less than 18.

These two stocks have been going in opposite directions over the past few years.

Better Buy in 2026: Pfizer or Eli Lilly? ↗

December 18, 2025

The United States economy is finally emerging from a period of unprecedented statistical darkness. Following the conclusion of the longest government shutdown in American history—a 43-day impasse that...

Topics World Trade

Flying Blind: How the Record 43-Day Shutdown Blinded the Fed and Rattled Global Markets

December 18, 2025

On this day in late 2025, Eli Lilly and Company (NYSE: LLY) stands as the undisputed titan of the global pharmaceutical industry. Having crossed the historic $1 trillion market capitalization threshold...

Topics Artificial Intelligence Bonds Credit Cards

The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony

December 18, 2025

Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry ↗

Topics Economy World Trade

December 18, 2025

Via Benzinga

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

December 18, 2025

From Pfizer Inc.

Via Business Wire

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun ↗

December 18, 2025

Via Benzinga

The Emotional Rollercoaster: How Fear and Greed Shape Investor Behavior in Market Downturns

December 17, 2025

The financial markets, often perceived as bastions of rational decision-making, are, in reality, deeply swayed by the powerful currents of human emotion. As the global economy navigates its inherent...

The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.

Topics Bonds Economy Supply Chain

These 2 Healthcare Stocks Just Declared Dividend Raises ↗

December 17, 2025

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

Topics Intellectual Property

December 17, 2025

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Via Stocktwits

Topics Government World Trade

Curious about the most active S&P500 stocks in today's session? ↗

December 17, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Moderna (MRNA) Stock Trades Up, Here Is Why

December 17, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the afternoon session after the broader biotech sector experienced a strong rebound, lifting shares of companies within the industry.

Via StockStory

Topics Artificial Intelligence

If I Could Only Buy and Hold a Single Stock, This Would Be It ↗

December 17, 2025

Pfizer's shares look attractive to investors willing to show patience.

FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain tumor concerns.

Topics Intellectual Property

FDA Approves Brain Tumor Warning For Pfizer's Depo-Provera Amid Lawsuit ↗

December 17, 2025

Via Benzinga

Topics Lawsuit

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back ↗

December 17, 2025

Pfizer & Merck are the boring intentional reset w/flat growth expectations. Pfizer now offers high dividends, Merck offers reliability.

Via Benzinga

Nasdaq Navigates Choppy Waters: Tech Index Shows Resilience Amidst Volatility and AI Bubble Concerns

December 17, 2025

The Nasdaq Composite (IXIC) has been on a rollercoaster ride as 2025 draws to a close, experiencing a notable three-day losing streak before showing a modest rebound on December 17. This recent...

New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new...

Topics Artificial Intelligence Economy Stocks

Dow Jones Soars to New Highs Amidst Economic Crosscurrents and AI Jitters

December 17, 2025

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.

Topics Artificial Intelligence Economy Government

The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now ↗

December 17, 2025